These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 2993022)
21. Characterization of vasoactive intestinal peptide receptors in human colonic epithelial cells. Broyart JP; Dupont C; Laburthe M; Rosselin G J Clin Endocrinol Metab; 1981 Apr; 52(4):715-21. PubMed ID: 6259191 [TBL] [Abstract][Full Text] [Related]
22. Characterization of adenylyl cyclase stimulated by VIP in rat and mouse peritoneal macrophage membranes. Pozo D; Segura JJ; Carrero I; Guijarro LG; Prieto JC; Calvo JR Biochim Biophys Acta; 1996 Jul; 1312(3):249-54. PubMed ID: 8703995 [TBL] [Abstract][Full Text] [Related]
23. Regulation of the rat proopiomelanocortin gene expression in AtT-20 cells. II: Effects of the pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide. Aoki Y; Iwasaki Y; Katahira M; Oiso Y; Saito H Endocrinology; 1997 May; 138(5):1930-4. PubMed ID: 9112389 [TBL] [Abstract][Full Text] [Related]
24. Binding of vasoactive intestinal peptide and its stimulation of adenylate cyclase through two classes of receptors in rat liver membranes. Effects of 12 secretin analogues and 2 secretin fragments. Waelbroeck M; Robberecht P; De Neef P; Chatelain P; Christophe J Biochim Biophys Acta; 1981 Nov; 678(1):83-90. PubMed ID: 6272875 [TBL] [Abstract][Full Text] [Related]
25. Restricted localization of functional vasoactive intestinal peptide (VIP) receptors in in vitro differentiated human colonic adenocarcinoma cells (HT29-D4). Fantini J; Martin JM; Luis J; Rémy L; Tirard A; Marvaldi J; Pichon J Eur J Cell Biol; 1988 Aug; 46(3):458-65. PubMed ID: 2846304 [TBL] [Abstract][Full Text] [Related]
26. Identification of cells responding to vasoactive intestinal peptide by measuring intracellular cyclic adenosine monophosphate in human colonic mucosa. Takahashi K; Fukushima K; Sasaki I; Ogawa H; Sato S; Naito H; Funayama Y; Matsuno S; Nagura H Scand J Gastroenterol; 2000 Jul; 35(7):737-41. PubMed ID: 10972178 [TBL] [Abstract][Full Text] [Related]
27. VIP interaction with intestinal epithelial cells and liver plasma membranes from hepatectomized rats. Prieto JC; Diaz-Juarez JL; Arilla E Peptides; 1986; 7 Suppl 1():273-8. PubMed ID: 3018701 [TBL] [Abstract][Full Text] [Related]
30. Receptors for vasoactive intestinal peptide and secretin on small intestinal epithelial cells. Binder HJ; Lemp GF; Gardner JD Am J Physiol; 1980 Mar; 238(3):G190-6. PubMed ID: 6245588 [TBL] [Abstract][Full Text] [Related]
31. Interaction of vasoactive intestinal peptide (VIP) and N-terminally modified VIP analogs with rat pancreatic, hepatic and pituitary membranes. Robberecht P; Coy DH; De Neef P; Camus JC; Cauvin A; Waelbroeck M; Christophe J Eur J Biochem; 1986 Aug; 159(1):45-9. PubMed ID: 3017717 [TBL] [Abstract][Full Text] [Related]
32. Combined ultrastructural and biochemical study of cellular processing of vasoactive intestinal peptide and its receptors in human colonic carcinoma cells in culture. Hejblum G; Gali P; Boissard C; Astesano A; Marie JC; Anteunis A; Hui Bon Hoa D; Rosselin G Cancer Res; 1988 Nov; 48(21):6201-10. PubMed ID: 2844402 [TBL] [Abstract][Full Text] [Related]
33. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis. Zawilska JB; Niewiadomski P; Nowak JZ Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130 [TBL] [Abstract][Full Text] [Related]
34. Cyclic AMP-dependent protein kinase in Molt 4b lymphoblasts: identification by photoaffinity labeling and activation in intact cells by vasoactive intestinal polypeptide (VIP) and peptide histidine isoleucine (PHI). O'Dorisio MS; Wood CL; Wenger GD; Vassalo LM J Immunol; 1985 Jun; 134(6):4078-86. PubMed ID: 2985703 [TBL] [Abstract][Full Text] [Related]
35. Cycloheximide induces accumulation of vasoactive intestinal peptide (VIP) binding sites at the cell surface of a human colonic adenocarcinoma cell line (HT29-D4). Evidence for the presence of an intracellular pool of VIP receptors. Luis J; Martin JM; el Battari A; Fantini J; Giannellini F; Marvaldi J; Pichon J Eur J Biochem; 1987 Sep; 167(2):391-6. PubMed ID: 3040409 [TBL] [Abstract][Full Text] [Related]
36. Peptide specificity for stimulation of corticotropin secretion: activation of overlapping pathways by the vasoactive intestinal peptide family and corticotropin-releasing factor. Westendorf JM; Schonbrunn A Endocrinology; 1985 Jun; 116(6):2528-35. PubMed ID: 2859986 [TBL] [Abstract][Full Text] [Related]
37. Vasoactive intestinal peptide: a potent stimulator of adenosine 3':5'-cyclic monophosphate accumulation in gut carcinoma cell lines in culture. Laburthe M; Rousset M; Boissard C; Chevalier G; Zweibaum A; Rosselin G Proc Natl Acad Sci U S A; 1978 Jun; 75(6):2772-5. PubMed ID: 208077 [TBL] [Abstract][Full Text] [Related]
38. Presence of vasoactive intestinal peptide receptors coupled to adenylate cyclase in rat lung membranes. Robberecht P; Chatelain P; De Neef P; Camus JC; Waelbroeck M; Christophe J Biochim Biophys Acta; 1981 Nov; 678(1):76-82. PubMed ID: 6118184 [TBL] [Abstract][Full Text] [Related]
39. Effect of resection of small intestine on the interaction of vasoactive intestinal peptide with rat colonic epithelial cells. Fernández-Moreno MD; Díaz-Juárez JL; Arilla E; Prieto JC Horm Metab Res; 1985 Jun; 17(6):289-92. PubMed ID: 2991100 [TBL] [Abstract][Full Text] [Related]
40. The C-terminal part of VIP is important for receptor binding and activation, as evidenced by chimeric constructs of VIP/secretin. Wulff B; Møller Knudsen S; Adelhorst K; Fahrenkrug J FEBS Lett; 1997 Aug; 413(3):405-8. PubMed ID: 9303545 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]